肝硬化门静脉高压性胃病的胃镜表现及相关因素分析

王文生; 朱光曦; 文良志; 陈东风

doi:10.3969/j.issn.1001-5256.2020.03.017

肝硬化门静脉高压性胃病的胃镜表现及相关因素分析

DOI: 10.3969/j.issn.1001-5256.2020.03.017

陆军军医大学大坪医院消化内科

基金项目:

陆军军医大学2019年度临床医学科研人才资助项目(2019XLC3045)；

详细信息

中图分类号: R575.2;R573
计量
- 文章访问数: 1362
- HTML全文浏览量: 59
- PDF下载量: 234
- 被引次数: 12
出版历程
- 收稿日期: 2019-11-29
- 出版日期: 2020-03-20

Gastroscopic manifestations of portal hypertensive gastropathy in liver cirrhosis and related factors

Department of Gastroenterology,Daping Hospital of Army Medical University

Research funding:

摘要

摘要: 目的探讨门静脉高压性胃病（PHG）胃镜下胃黏膜特征及其与食管胃静脉曲张、溃疡病及肝硬化并发症之间的关系。方法回顾性分析2012年8月-2018年6月陆军军医大学大坪医院867例肝硬化患者临床资料,统计其胃镜下食管胃静脉曲张、PHG、溃疡病发生的情况,收集肝硬化并发自发性细菌性腹膜炎、肝性脑病、原发性肝癌的数据资料。计数资料组间比较采用χ2检验,相关性分析采用Spearman相关性检验。结果肝硬化患者PHG发生率高达66. 2%（574/867）,轻度PHG胃黏膜改变以红点灶（68. 6%）和蛇皮征（56. 8%）为主,而重度PHG以弥漫红斑为主（76. 5%）。PHG在不同程度的食管静脉曲张中发生率差异显著（χ2=304. 712,P <0. 05）,并且随着食管静脉曲张加重,PHG程度亦越来越重（r=0. 515,P <0. 05）。不同程度胃静脉曲张的患者PHG发生率差异有统计学意义（χ2=81. 004,P <0. 05）,且PHG程度与胃静脉曲张程度相关（r=0. 292,P <0. 05...
- 门静脉高压性胃病 /
- 肝硬化 /
- 食管和胃静脉曲张 /
- 胃肠出血
Abstract: Objective To investigate the gastroscopic manifestations of gastric mucosa in portal hypertensive gastropathy( PHG) and the association of PHG with gastroesophageal varices,ulcers,and liver cirrhosis complications. Methods A retrospective analysis was performed for the clinical data of 867 patients with liver cirrhosis who were treated in Daping Hospital of Army Medical University from August 2012 to June 2018,and the incidence rates of gastroesophageal varices,PHG,and ulcers were recorded. Meanwhile,the data of spontaneous bacterial peritonitis( SBP),hepatic encephalopathy( HE),and hepatocellular carcinoma( HCC) were collected. The chi-square test was used for comparison of categorical data between groups,and a Spearman correlation analysis was also performed. Results The incidence rate of PHG in the patients with liver cirrhosis reached 66. 2%( 574/867),and gastric mucosa abnormalities in mild PHG were mainly red-spot lesions( 68. 6%) and snakeskin( 56. 8%),while diffuse erythema( 76. 5%) was the main gastric mucosa abnormality in severe PHG.There was a significant difference in the incidence rate of PHG between the patients with different severities of esophageal varices( χ2=304. 712,P < 0. 05),and the severity of PHG increased with the aggravation of esophageal varices( r = 0. 515,P < 0. 05). There was a significant difference in the incidence rate of PHG between the patients with different severities of gastric varices( χ2= 81. 004,P < 0. 05),and the severity of PHG was positively correlated with that of gastric varices( r = 0. 292,P < 0. 05). There was a significant difference in the incidence rate of PHG between the patients with varices at different locations( χ2= 41. 361,P < 0. 05); the patients with gastric varices alone had the lowest incidence rate of PHG( 34. 8%) and only had mild PHG,and those with gastroesophageal varices had the highest incidence rate of PHG( 85. 6%). Among the patients without PHG,71( 24. 2%) were hospitalized due to hematemesis and/or tarry stool,and among the 574 patients with PHG,316( 55. 1%) were hospitalized,and there was a significant difference between the two groups( χ2=74. 562,P < 0. 05). Conclusion Patients with different severities of PHG have different features of gastric mucosa abnormalities. The development and severity of PHG are closely associated with the severity of gastroesophageal varices and are important causes of gastrointestinal bleeding in liver cirrhosis. PHG should be treated and prevented to reduce the risk and complications of gastrointestinal bleeding.
- portal hypertensive gastropathy /
- liver cirrhosis /
- esophageal and gastric varices /
- gastrointestinal hemorrhage

HTML全文

参考文献(23)

[1] McCORMACK TT,SIMS J,EYRE-BROOK I,et al. Gastric lesions in portal hypertension:Inflammatory gastritis or congestive gastropathy?[J]. Gut,1985,26(11):1226-1232.

[2] URRUNAGA NH,ROCKEY DC. Portal hypertensive gastropathy and colopathy[J]. Clin Liver Dis,2014,18(2):389-406.

[3] GONZALEZ-GONZALEZ JA,GARCIA-COMPEAN D,VAZQUEZ-ELIZONDO G,et al. Nonvariceal upper gastrointestinal bleeding in patients with liver cirrhosis. Clinical features,outcomes and predictors of in-hospital mortality. A prospective study[J]. Ann Hepatol,2011,10(3):287-295.

[4] Chinese Society of Hepatology,Chinese Medical Association;Chinese Society of Gastroenterology,Chinese Medical Association; Chinese Society of Endoscopy,Chinese Medical Association. Guidelines for the diagnosis and treatment of esophageal and gastric variceal bleeding in cirrhotic portal hypertension[J]. J Clin Hepatol,2016,32(2):203-219.(in Chinese)中华医学会肝病学分会，中华医学会消化病学分会，中华医学会内镜学分会．肝硬化门静脉高压食管胃静脉曲张出血的防治指南[J]．临床肝胆病杂志，2016,32(2):203-219.

[5] BLEI AT,CORDOBA J. Hepatic encephalopathy[J]. Am J Gastroenterol,2001,96(7):1968-1976.

[6] National Health and Family Planning Commission of the People's Republic of China. Diagnosis,management,and treatment of hepatocellular carcinoma(V2017)[J]. J Clin Hepatol,2017,33(8):1419-1431.(in Chinese)中华人民共和国国家卫生和计划生育委员会．原发性肝癌诊疗规范(2017年版)[J]．临床肝胆病杂志，2017,33(8):1419-1431.

[7] GJEORGJIEVSKI M,CAPPELL MS. Portal hypertensive gastropathy:A systematic review of the pathophysiology,clinical presentation,natural history and therapy[J]. World J Hepatol,2016,8(4):231-262.

[8] WU Q,SHEN L,CHU J,et al. Characterization of uncommon portosystemic collateral circulations in patients with hepatic cirrhosis[J]. Oncol Lett,2015,9(1):347-350.

[9] de MACEDO GF,FERREIRA FG,RIBEIRO MA,et al. Reliability in endoscopic diagnosis of portal hypertensive gastropathy[J]. World J Gastrointest Endosc,2013,5(7):323-331.

[10] KUMAR A,MISHRA SR,SHARMA P,et al. Clinical,laboratory,and hemodynamic parameters in portal hypertensive gastropathy:A study of 254 cirrhotics[J]. J Clin Gastroenterol,2010,44(4):294-300.

[11] ABBASI A,BHUTTO AR,BUTT N,et al. Frequency of portal hypertensive gastropathy and its relationship with biochemical,haematological and endoscopic features in cirrhosis[J]. J Coll Physicians Surg Pak,2011,21(12):723-726.

[12] IWAO T,TOYONAGA A,OHO K,et al. Portal-hypertensive gastropathy develops less in patients with cirrhosis and fundal varices[J]. J Hepatol,1997,26(6):1235-1241.

[13] BELLIS L,NICODEMO S,GALOSSI A,et al. Hepatic venous pressure gradient does not correlate with the presence and the severity of portal hypertensive gastropathy in patients with liver cirrhosis[J].J Gastrointestin Liver Dis,2007,16(3):273-277.

[14] SALEEM K,BAIG FA,NIDA M,et al. Correlation between severity of portal hypertensive gastropathy and size of oesophageal varices in cirrhotic hepatitis-C patients[J]. J Ayub Med Coll Abbottabad,2018,30(1):54-57.

[15] ZARDI EM,PIPITA ME,LICHINCHI D,et al. Five-year-term results in cirrhotics without varices,either affected or not by portal hypertensive gastropathy[J]. Eur J Gastroenterol Hepatol,2019,31(4):528-533.

[16] ZHAO YX,CAO MB. Risk factors for esophageal varices bleeding in patients with liver cirrhosis[J]. J Xinxiang Med Univ,2018,35(10):869-873.(in Chinese)赵迤璇，曹名波．肝硬化并发食管静脉曲张破裂出血的相关危险因素分析[J]．新乡医学院学报，2018,35(10):869-873.

[17] ZHU YD,XIE XC,XIANG B,et al. The relationship between chronic hepatitis B,hepatitis B cirrhosis and peptic ulcer[J].J Chin Physician,2011,13(11):1514-1515.(in Chinese)朱元东，谢欣城，项波，等．慢性乙型肝炎、乙肝肝硬化与消化性溃疡关系的探讨[J]．中国医师杂志，2011,13(11):1514-1515.

[18] BANG C,BAIK GH,KIM JH,et al. Peptic ulcer disease in liver cirrhosis and chronic hepatitis:Impact of portal hypertension[J]. Scand J Gastroenterol,2014,49(9):1051-1057.

[19] VENKATESH PG,PARASA S,NJEI B,et al. Increased mortality with peptic ulcer bleeding in patients with both compensated and decompensated cirrhosis[J]. Gastrointest Endosc,2014,79(4):605-614.

[20] AUROUX J,LAMARQUE D,ROUDOT-THORAVAL F,et al.Gastroduodenal ulcer and erosions are related to portal hypertensive gastropathy and recent alcohol intake in cirrhotic patients[J]. Dig Dis Sci,2003,48(6):1118-1123.

[21] LI QQ,LIAO JT,CHEN G,et al. Clinical study between hepatogenic ulcer and both helicobacter pylori infection and portal hypertensive gastropathy[J]. China Modern Med,2011,18(30):25-27.(in Chinese)李清清，廖江涛，陈钢，等．肝源性溃疡与幽门螺杆菌及门脉高压性胃病关系的研究[J]．中国当代医药，2011,18(30):25-27.

[22] HU JK,LI XM,GU BH,et al. Helicobacter pylori and portal hypertensive gastropathy[J]. Hepatobiliary Pancreat Dis Int,2018,17(6):578-580.

[23] BANG CS,KIM HS,SUK KT,et al. Portal hypertensive gastropathy as a prognostic index in patients with liver cirrhosis[J]. BMC Gastroenterol,2016,16(1):93-102.

施引文献

期刊类型引用(9)

1.	关结红，张晖，凌明强，杨燕君. 多学科互联网+延续护理模式对肝硬化门脉高压食管胃静脉曲张破裂出血患者的干预效果. 现代医药卫生. 2024(03): 492-495 . 百度学术
2.	倪友琼，胡乃毅，张紫涵. PHG患者中医证候分型与疾病严重程度的关系研究. 四川中医. 2024(01): 83-86 . 百度学术
3.	黄学，姜志勇，贾秋红. 内镜套扎术分别联合组织溶胶“三明治”注射及聚桂醇注射治疗EVB的效果及安全性对比. 临床和实验医学杂志. 2023(22): 2387-2391 . 百度学术
4.	骆成俊，李黎，韩建雄，朱晓娟，刘彦. 肝癌患者门静脉高压性胃病的胃镜表现及相关影响因素分析. 临床消化病杂志. 2022(01): 12-16 . 百度学术
5.	唐学良，张晖，凌明强. 肝硬化食管静脉曲张破裂出血的临床特点与危险因素分析. 国际医药卫生导报. 2022(19): 2753-2757 . 百度学术
6.	王维杰，朱荣涛，梁若鹏，李健，张弛弦，李德旭. 冠腔分流联合脾切除术在门静脉高压症中的应用价值. 临床肝胆病杂志. 2021(04): 898-901 . 本站查看
7.	林裕锋，黄幸红，黎杨杨，许秋桂. 血清胃蛋白酶原和胰高血糖素在肝硬化门脉高压性胃病中的应用研究. 中国现代药物应用. 2021(14): 85-87 . 百度学术
8.	李广鉴，杜丽明，孙秋，王文鸽，李晨，赵利. 清中汤合丹参饮治疗门静脉高压性胃病临床研究. 河北中医. 2021(06): 938-942 . 百度学术
9.	黎杨杨，林裕锋，陈冬玲. 肝硬化门脉高压性胃病血清胃蛋白酶原的变化和意义分析. 中外医学研究. 2020(20): 50-52 . 百度学术